{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:12:10Z","timestamp":1787497930276,"version":"build-2736575974"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["466989\/2014\u20138"],"award-info":[{"award-number":["466989\/2014\u20138"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007762","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Translacional em Medicina","doi-asserted-by":"crossref","award":["#465458\/2014\u20139"],"award-info":[{"award-number":["#465458\/2014\u20139"]}],"id":[{"id":"10.13039\/501100007762","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12035-020-02203-x","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T03:02:55Z","timestamp":1605754975000},"page":"1517-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Parkinson\u2019s Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-5786","authenticated-orcid":false,"given":"D. M.","family":"Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"De Bastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Klamt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2203_CR1","doi-asserted-by":"publisher","unstructured":"Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, Abyu GY, Ahmed MB, Aichour AN, Aichor I, ... & Aichour MTEE(2017) Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877\u2013897. doi:https:\/\/doi.org\/10.1016\/S1474-4422(17)30299-5","DOI":"10.1016\/S1474-4422(17)30299-5"},{"issue":"11","key":"2203_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"2203_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fneur.2018.00156","volume":"9","author":"L Marsili","year":"2018","unstructured":"Marsili L, Rizzo G, Colosimo C (2018) Diagnostic criteria for Parkinson\u2019s disease: from James Parkinson to the concept of prodromal disease. Front Neurol 9:156. https:\/\/doi.org\/10.3389\/fneur.2018.00156","journal-title":"Front Neurol"},{"issue":"9996","key":"2203_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"2","key":"2203_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2203_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10548-018-0675-2","volume":"32","author":"J Kunst","year":"2019","unstructured":"Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I (2019) Patterns of grey matter atrophy at different stages of Parkinson\u2019s and Alzheimer\u2019s diseases and relation to cognition. Brain Topogr 32(1):142\u2013160. https:\/\/doi.org\/10.1007\/s10548-018-0675-2","journal-title":"Brain Topogr"},{"key":"2203_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fneur.2018.00138","volume":"9","author":"T Prell","year":"2018","unstructured":"Prell T (2018) Structural and functional brain patterns of non-motor syndromes in Parkinson\u2019s disease. Front Neurol 9:138. https:\/\/doi.org\/10.3389\/fneur.2018.00138","journal-title":"Front Neurol"},{"key":"2203_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.05.018","volume":"93","author":"B Chen","year":"2017","unstructured":"Chen B, Wang S, Sun W, Shang X, Liu H, Liu G, Gao J, Fan G (2017) Functional and structural changes in gray matter of Parkinson\u2019s disease patients with mild cognitive impairment. Eur J Radiol 93:16\u201323. https:\/\/doi.org\/10.1016\/j.ejrad.2017.05.018","journal-title":"Eur J Radiol"},{"issue":"9\u201310","key":"2203_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo N, Mart\u00edn V, Santpere G, Mar\u00edn R, Torrent L, Ferrer I, D\u00edaz M (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol Med 17(9\u201310):1107\u20131118. https:\/\/doi.org\/10.2119\/molmed.2011.00119","journal-title":"Mol Med"},{"issue":"1","key":"2203_CR10","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harbor Perspectives in Medicine 2(1):a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6","key":"2203_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM (2016) Genetics of Parkinson\u2019s disease. Mol Cell Probes 30(6):386\u2013396. https:\/\/doi.org\/10.1016\/j.mcp.2016.11.001","journal-title":"Mol Cell Probes"},{"issue":"12","key":"2203_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/s1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15(12):1257\u20131272. https:\/\/doi.org\/10.1016\/s1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"2203_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2010.10.022","volume":"45","author":"JG Greene","year":"2012","unstructured":"Greene JG (2012) Current status and future directions of gene expression profiling in Parkinson\u2019s disease. Neurobiol Dis 45(1):76\u201382. https:\/\/doi.org\/10.1016\/j.nbd.2010.10.022","journal-title":"Neurobiol Dis"},{"issue":"6","key":"2203_CR14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/archneur.62.6.917","volume":"62","author":"MA Hauser","year":"2005","unstructured":"Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV et al (2005) Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 62(6):917\u2013921. https:\/\/doi.org\/10.1001\/archneur.62.6.917","journal-title":"Arch Neurol"},{"issue":"3","key":"2203_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004955","volume":"4","author":"GT Sutherland","year":"2009","unstructured":"Sutherland GT, Matigian NA, Chalk AM, Anderson MJ, Silburn PA, Mackay-Sim A, Wells CA, Mellick GD (2009) A cross-study transcriptional analysis of Parkinson\u2019s disease. PLoS One 4(3):e4955. https:\/\/doi.org\/10.1371\/journal.pone.0004955","journal-title":"PLoS One"},{"issue":"1","key":"2203_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","volume":"7","author":"LB Moran","year":"2006","unstructured":"Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson\u2019s disease. Neurogenetics 7(1):1\u201311. https:\/\/doi.org\/10.1007\/s10048-005-0020-2","journal-title":"Neurogenetics"},{"key":"2203_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biosystems.2018.10.008","volume":"174","author":"S Barbosa","year":"2018","unstructured":"Barbosa S, Niebel B, Wolf S, Mauch K, Takors R (2018) A guide to gene regulatory network inference for obtaining predictive solutions: underlying assumptions and fundamental biological and data constraints. Biosystems 174:37\u201348. https:\/\/doi.org\/10.1016\/j.biosystems.2018.10.008","journal-title":"Biosystems"},{"issue":"1","key":"2203_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbagrm.2016.09.003","volume":"1860","author":"M Banf","year":"2017","unstructured":"Banf M, Rhee SY (2017) Computational inference of gene regulatory networks: approaches, limitations and opportunities. Biochim Biophys Acta Gene Regul Mech 1860(1):41\u201352. https:\/\/doi.org\/10.1016\/j.bbagrm.2016.09.003","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"2203_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12967-015-0492-2","volume":"13","author":"A Remo","year":"2015","unstructured":"Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, Bensmail H, Birnbaum D et al (2015) Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. J Transl Med 13:138. https:\/\/doi.org\/10.1186\/s12967-015-0492-2","journal-title":"J Transl Med"},{"issue":"7279","key":"2203_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279):318\u2013325. https:\/\/doi.org\/10.1038\/nature08712","journal-title":"Nature"},{"key":"2203_CR21","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/ncomms3464","volume":"4","author":"MN Fletcher","year":"2013","unstructured":"Fletcher MN, Castro MA, Wang X, de Santiago I, O\u2019Reilly M, Chin SF, Rueda OM, Caldas C et al (2013) Master regulators of FGFR2 signalling and breast cancer risk. Nat Commun 4:2464. https:\/\/doi.org\/10.1038\/ncomms3464","journal-title":"Nat Commun"},{"key":"2203_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.78","volume":"6","author":"B Pfaffenseller","year":"2016","unstructured":"Pfaffenseller B, da Silva Magalh\u00e3es PV, De Bastiani MA, Castro MA, Gallitano AL, Kapczinski F, Klamt F (2016) Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3. Transl Psychiatry 6:e805. https:\/\/doi.org\/10.1038\/tp.2016.78","journal-title":"Transl Psychiatry"},{"issue":"1","key":"2203_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-018-0394-7","volume":"10","author":"DM Vargas","year":"2018","unstructured":"Vargas DM, De Bastiani MA, Zimmer ER, Klamt F (2018) Alzheimer\u2019s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. Alzheimers Res Ther 10(1):59. https:\/\/doi.org\/10.1186\/s13195-018-0394-7","journal-title":"Alzheimers Res Ther"},{"issue":"15","key":"2203_CR24","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1002\/cam4.2493","volume":"8","author":"MA De Bastiani","year":"2019","unstructured":"De Bastiani MA, Klamt F (2019) Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates. Cancer Med 8(15):6717\u20136729. https:\/\/doi.org\/10.1002\/cam4.2493","journal-title":"Cancer Med"},{"issue":"2","key":"2203_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/ijms17020246","volume":"17","author":"W Zhou","year":"2016","unstructured":"Zhou W, Wang Y, Lu A, Zhang G (2016) Systems pharmacology in small molecular drug discovery. Int J Mol Sci 17(2):246. https:\/\/doi.org\/10.3390\/ijms17020246","journal-title":"Int J Mol Sci"},{"issue":"5795","key":"2203_CR26","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929\u20131935. https:\/\/doi.org\/10.1126\/science.1132939","journal-title":"Science"},{"issue":"1","key":"2203_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086299","volume":"9","author":"FH Chung","year":"2014","unstructured":"Chung FH, Chiang YR, Tseng AL, Sung YC, Lu J, Huang MC, Ma N, Lee HC (2014) Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma. PLoS One 9(1):e86299. https:\/\/doi.org\/10.1371\/journal.pone.0086299","journal-title":"PLoS One"},{"issue":"96","key":"2203_CR28","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","volume":"3","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM et al (2011) Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 3(96):96ra76. https:\/\/doi.org\/10.1126\/scitranslmed.3002648","journal-title":"Sci Transl Med"},{"issue":"2","key":"2203_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1471-4159.2011.07432.x","volume":"119","author":"D Trabzuni","year":"2011","unstructured":"Trabzuni D, Ryten M, Walker R, Smith C, Imran S, Ramasamy A, Weale ME, Hardy J (2011) Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem 119(2):275\u2013282. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07432.x","journal-title":"J Neurochem"},{"issue":"1","key":"2203_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ng.3458","volume":"48","author":"MA Castro","year":"2016","unstructured":"Castro MA, de Santiago I, Campbell TM, Vaughn C, Hickey TE, Ross E, Tilley WD, Markowetz F et al (2016) Regulators of genetic risk of breast cancer identified by integrative network analysis. Nat Genet 48(1):12\u201321. https:\/\/doi.org\/10.1038\/ng.3458","journal-title":"Nat Genet"},{"issue":"6","key":"2203_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA et al (2007) A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 3(6):e98. https:\/\/doi.org\/10.1371\/journal.pgen.0030098","journal-title":"PLoS Genet"},{"issue":"6","key":"2203_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00401-012-1027-z","volume":"124","author":"PF Durrenberger","year":"2012","unstructured":"Durrenberger PF, Fernando FS, Magliozzi R, Kashefi SN, Bonnert TP, Ferrer I, Seilhean D, Nait-Oumesmar B et al (2012) Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe study. Acta Neuropathol 124(6):893\u2013903. https:\/\/doi.org\/10.1007\/s00401-012-1027-z","journal-title":"Acta Neuropathol"},{"issue":"7","key":"2203_CR33","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-014-1293-0","volume":"122","author":"PF Durrenberger","year":"2015","unstructured":"Durrenberger PF, Fernando FS, Kashefi SN, Bonnert TP, Seilhean D, Nait-Oumesmar B, Schmitt A, Gebicke-Haerter PJ et al (2015) Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J Neural Transm (Vienna) 122(7):1055\u20131068. https:\/\/doi.org\/10.1007\/s00702-014-1293-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"2203_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128651","volume":"10","author":"AA Dijkstra","year":"2015","unstructured":"Dijkstra AA, Ingrassia A, de Menezes RX, van Kesteren RE, Rozemuller AJ, Heutink P, van de Berg WD (2015) Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson\u2019s disease. PLoS One 10(6):e0128651. https:\/\/doi.org\/10.1371\/journal.pone.0128651","journal-title":"PLoS One"},{"issue":"2","key":"2203_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10048-006-0077-6","volume":"8","author":"DC Duke","year":"2007","unstructured":"Duke DC, Moran LB, Pearce RK, Graeber MB (2007) The medial and lateral substantia nigra in Parkinson\u2019s disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8(2):83\u201394. https:\/\/doi.org\/10.1007\/s10048-006-0077-6","journal-title":"Neurogenetics"},{"issue":"10","key":"2203_CR36","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80. https:\/\/doi.org\/10.1186\/gb-2004-5-10-r80","journal-title":"Genome Biol"},{"key":"2203_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1471-2105-9-461","volume":"9","author":"PE Meyer","year":"2008","unstructured":"Meyer PE, Lafitte F, Bontempi G (2008) minet: A R\/Bioconductor package for inferring large transcriptional networks using mutual information. BMC Bioinformatics 9:461. https:\/\/doi.org\/10.1186\/1471-2105-9-461","journal-title":"BMC Bioinformatics"},{"key":"2203_CR38","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1471-2105-7-s1-s7","volume":"7 Suppl 1","author":"AA Margolin","year":"2006","unstructured":"Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, Califano A (2006) ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 Suppl 1:S7. https:\/\/doi.org\/10.1186\/1471-2105-7-s1-s7","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"2203_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nprot.2006.106","volume":"1","author":"AA Margolin","year":"2006","unstructured":"Margolin AA, Wang K, Lim WK, Kustagi M, Nemenman I, Califano A (2006) Reverse engineering cellular networks. Nat Protoc 1(2):662\u2013671. https:\/\/doi.org\/10.1038\/nprot.2006.106","journal-title":"Nat Protoc"},{"issue":"4","key":"2203_CR40","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2012-13-4-r29","volume":"13","author":"MA Castro","year":"2012","unstructured":"Castro MA, Wang X, Fletcher MN, Meyer KB, Markowetz F (2012) RedeR: R\/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations. Genome Biol 13(4):R29. https:\/\/doi.org\/10.1186\/gb-2012-13-4-r29","journal-title":"Genome Biol"},{"key":"2203_CR41","doi-asserted-by":"publisher","unstructured":"Wickham H (2016) ggplot2 : elegant graphics for data analysis, vol 1v. Use R! 2197-5736, Second Edition edn. Springer International Publishing Imprint: Springer. doi:https:\/\/doi.org\/10.1007\/978-3-319-24277-4","DOI":"10.1007\/978-3-319-24277-4"},{"issue":"43","key":"2203_CR42","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2203_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"issue":"1","key":"2203_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, James M, Middleton FA, Davis RL (2005) Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137B(1):5\u201316. https:\/\/doi.org\/10.1002\/ajmg.b.30195","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2203_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fphar.2018.00697","volume":"9","author":"MA De Bastiani","year":"2018","unstructured":"De Bastiani MA, Pfaffenseller B, Klamt F (2018) Master regulators connectivity map: a transcription factors-centered approach to drug repositioning. Front Pharmacol 9:697. https:\/\/doi.org\/10.3389\/fphar.2018.00697","journal-title":"Front Pharmacol"},{"issue":"5","key":"2203_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12264-017-0168-4","volume":"33","author":"R Wang","year":"2017","unstructured":"Wang R, Yang S, Nie T, Zhu G, Feng D, Yang Q (2017) Transcription factors: potential cell death markers in Parkinson\u2019s disease. Neurosci Bull 33(5):552\u2013560. https:\/\/doi.org\/10.1007\/s12264-017-0168-4","journal-title":"Neurosci Bull"},{"key":"2203_CR47","doi-asserted-by":"publisher","first-page":"6097107","DOI":"10.1155\/2016\/6097107","volume":"2016","author":"FX Blaudin de Th\u00e9","year":"2016","unstructured":"Blaudin de Th\u00e9 FX, Rekaik H, Prochiantz A, Fuchs J, Joshi RL (2016) Neuroprotective transcription factors in animal models of Parkinson disease. Neural Plast 2016:6097107. https:\/\/doi.org\/10.1155\/2016\/6097107","journal-title":"Neural Plast"},{"key":"2203_CR48","doi-asserted-by":"publisher","first-page":"6025358","DOI":"10.1155\/2017\/6025358","volume":"2017","author":"J Tippabathani","year":"2017","unstructured":"Tippabathani J, Nellore J, Radhakrishnan V, Banik S, Kapoor S (2017) Identification of NURR1 (exon 4) and FOXA1 (exon 3) haplotypes associated with mRNA expression levels in peripheral blood lymphocytes of Parkinson\u2019s patients in small Indian population. Parkinsons Dis 2017:6025358. https:\/\/doi.org\/10.1155\/2017\/6025358","journal-title":"Parkinsons Dis"},{"issue":"12","key":"2203_CR49","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.15252\/emmm.201505439","volume":"7","author":"R Fern\u00e1ndez-Santiago","year":"2015","unstructured":"Fern\u00e1ndez-Santiago R, Carballo-Carbajal I, Castellano G, Torrent R, Richaud Y, S\u00e1nchez-Dan\u00e9s A, Vilarrasa-Blasi R, S\u00e1nchez-Pla A et al (2015) Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson\u2019s disease patients. EMBO Mol Med 7(12):1529\u20131546. https:\/\/doi.org\/10.15252\/emmm.201505439","journal-title":"EMBO Mol Med"},{"issue":"12","key":"2203_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050325","volume":"5","author":"R Kittappa","year":"2007","unstructured":"Kittappa R, Chang WW, Awatramani RB, McKay RD (2007) The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol 5(12):e325. https:\/\/doi.org\/10.1371\/journal.pbio.0050325","journal-title":"PLoS Biol"},{"key":"2203_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fncel.2014.00275","volume":"8","author":"A Domanskyi","year":"2014","unstructured":"Domanskyi A, Alter H, Vogt MA, Gass P, Vinnikov IA (2014) Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance. Front Cell Neurosci 8:275. https:\/\/doi.org\/10.3389\/fncel.2014.00275","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"2203_CR52","doi-asserted-by":"publisher","first-page":"510","DOI":"10.15252\/emmm.201404610","volume":"7","author":"SM Oh","year":"2015","unstructured":"Oh SM, Chang MY, Song JJ, Rhee YH, Joe EH, Lee HS, Yi SH, Lee SH (2015) Combined Nurr1 and Foxa2 roles in the therapy of Parkinson\u2019s disease. EMBO Mol Med 7(5):510\u2013525. https:\/\/doi.org\/10.15252\/emmm.201404610","journal-title":"EMBO Mol Med"},{"issue":"18","key":"2203_CR53","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.15252\/embj.201593725","volume":"35","author":"JC Villaescusa","year":"2016","unstructured":"Villaescusa JC, Li B, Toledo EM, Rivetti di Val Cervo P, Yang S, Stott SR, Kaiser K, Islam S et al (2016) A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson\u2019s disease. EMBO J 35(18):1963\u20131978. https:\/\/doi.org\/10.15252\/embj.201593725","journal-title":"EMBO J"},{"issue":"16","key":"2203_CR54","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1242\/dev.094565","volume":"140","author":"JV Veenvliet","year":"2013","unstructured":"Veenvliet JV, Dos Santos MT, Kouwenhoven WM, von Oerthel L, Lim JL, van der Linden AJ, Koerkamp MJ, Holstege FC et al (2013) Specification of dopaminergic subsets involves interplay of En1 and Pitx3. Development 140(16):3373\u20133384. https:\/\/doi.org\/10.1242\/dev.094565","journal-title":"Development"},{"issue":"1","key":"2203_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/adr-180072","volume":"2","author":"JP Bennett","year":"2018","unstructured":"Bennett JP, Keeney PM (2018) RNA-sequencing reveals similarities and differences in gene expression in vulnerable brain tissues of Alzheimer\u2019s and Parkinson\u2019s diseases. J Alzheimers Dis Rep 2(1):129\u2013137. https:\/\/doi.org\/10.3233\/adr-180072","journal-title":"J Alzheimers Dis Rep"},{"issue":"9","key":"2203_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220995","volume":"14","author":"MK Sakharkar","year":"2019","unstructured":"Sakharkar MK, Kashmir Singh SK, Rajamanickam K, Mohamed Essa M, Yang J, Chidambaram SB (2019) A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson\u2019s disease. PLoS One 14(9):e0220995. https:\/\/doi.org\/10.1371\/journal.pone.0220995","journal-title":"PLoS One"},{"key":"2203_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12920-016-0173-x","volume":"9","author":"M Cruz-Monteagudo","year":"2016","unstructured":"Cruz-Monteagudo M, Borges F, Paz-Y-Mi\u00f1o C, Cordeiro MN, Rebelo I, Perez-Castillo Y, Helguera AM, S\u00e1nchez-Rodr\u00edguez A et al (2016) Efficient and biologically relevant consensus strategy for Parkinson\u2019s disease gene prioritization. BMC Med Genet 9:12. https:\/\/doi.org\/10.1186\/s12920-016-0173-x","journal-title":"BMC Med Genet"},{"issue":"6","key":"2203_CR58","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1007\/s12035-017-0686-0","volume":"55","author":"X Wang","year":"2018","unstructured":"Wang X, Zhai H, Wang F (2018) 6-OHDA induces oxidation of F-box protein Fbw7\u03b2 by chaperone-mediated autophagy in Parkinson\u2019s model. Mol Neurobiol 55(6):4825\u20134833. https:\/\/doi.org\/10.1007\/s12035-017-0686-0","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2203_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/mgg3.18","volume":"1","author":"X Liu","year":"2013","unstructured":"Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L et al (2013) Increased rate of sporadic and recurrent rare genic copy number variants in Parkinson\u2019s disease among Ashkenazi Jews. Mol Genet Genomic Med 1(3):142\u2013154. https:\/\/doi.org\/10.1002\/mgg3.18","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"2203_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"CH Yeh","year":"2018","unstructured":"Yeh CH, Bellon M, Nicot C (2018) FBXW7: a critical tumor suppressor of human cancers. Mol Cancer 17(1):115. https:\/\/doi.org\/10.1186\/s12943-018-0857-2","journal-title":"Mol Cancer"},{"issue":"18","key":"2203_CR61","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1128\/mcb.00535-13","volume":"33","author":"S Ekholm-Reed","year":"2013","unstructured":"Ekholm-Reed S, Goldberg MS, Schlossmacher MG, Reed SI (2013) Parkin-dependent degradation of the F-box protein Fbw7\u03b2 promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1. Mol Cell Biol 33(18):3627\u20133643. https:\/\/doi.org\/10.1128\/mcb.00535-13","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2203_CR62","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1471-4159.1991.tb08277.x","volume":"57","author":"N Takei","year":"1991","unstructured":"Takei N, Kondo J, Nagaike K, Ohsawa K, Kato K, Kohsaka S (1991) Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J Neurochem 57(4):1178\u20131184","journal-title":"J Neurochem"},{"issue":"3","key":"2203_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0168-0102(94)00849-B","volume":"21","author":"T Hattori","year":"1995","unstructured":"Hattori T, Takei N, Mizuno Y, Kato K, Kohsaka S (1995) Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci Res 21(3):191\u2013198","journal-title":"Neurosci Res"},{"issue":"4","key":"2203_CR64","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1128\/MCB.11.4.2154","volume":"11","author":"R Ray","year":"1991","unstructured":"Ray R, Miller DM (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11(4):2154\u20132161","journal-title":"Mol Cell Biol"},{"issue":"8","key":"2203_CR65","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1074\/jbc.275.8.5958","volume":"275","author":"A Subramanian","year":"2000","unstructured":"Subramanian A, Miller DM (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275(8):5958\u20135965","journal-title":"J Biol Chem"},{"issue":"6","key":"2203_CR66","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1046\/j.1471-4159.1994.63062048.x","volume":"63","author":"K Nakajima","year":"1994","unstructured":"Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S (1994) Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. J Neurochem 63(6):2048\u20132057","journal-title":"J Neurochem"},{"issue":"4","key":"2203_CR67","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1471-4159.2009.06397.x","volume":"111","author":"DA Butterfield","year":"2009","unstructured":"Butterfield DA, Lange ML (2009) Multifunctional roles of enolase in Alzheimer\u2019s disease brain: beyond altered glucose metabolism. J Neurochem 111(4):915\u2013933. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06397.x","journal-title":"J Neurochem"},{"issue":"1","key":"2203_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4049\/jimmunol.1102073","volume":"189","author":"S Bae","year":"2012","unstructured":"Bae S, Kim H, Lee N, Won C, Kim HR, Hwang YI, Song YW, Kang JS et al (2012) \u03b1-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol 189(1):365\u2013372. https:\/\/doi.org\/10.4049\/jimmunol.1102073","journal-title":"J Immunol"},{"issue":"8","key":"2203_CR69","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1523\/JNEUROSCI.15-08-05727.1995","volume":"15","author":"GE Lyons","year":"1995","unstructured":"Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci 15(8):5727\u20135738","journal-title":"J Neurosci"},{"issue":"5","key":"2203_CR70","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.neuro.2011.05.019","volume":"32","author":"H She","year":"2011","unstructured":"She H, Mao Z (2011) Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. Neurotoxicology 32(5):563\u2013566. https:\/\/doi.org\/10.1016\/j.neuro.2011.05.019","journal-title":"Neurotoxicology"},{"issue":"6","key":"2203_CR71","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR et al (2013) Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1\u03b1 transcription. Cell 155(6):1351\u20131364. https:\/\/doi.org\/10.1016\/j.cell.2013.11.009","journal-title":"Cell"},{"issue":"6","key":"2203_CR72","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1471-4159.2012.07860.x","volume":"122","author":"H She","year":"2012","unstructured":"She H, Yang Q, Mao Z (2012) Neurotoxin-induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response. J Neurochem 122(6):1203\u20131210. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07860.x","journal-title":"J Neurochem"},{"key":"2203_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuropharm.2017.08.014","volume":"126","author":"B Guo","year":"2017","unstructured":"Guo B, Hu S, Zheng C, Wang H, Luo F, Li H, Cui W, Yang X et al (2017) Substantial protection against MPTP-associated Parkinson\u2019s neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B. Neuropharmacology 126:12\u201324. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.014","journal-title":"Neuropharmacology"},{"issue":"26","key":"2203_CR74","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1021\/acs.jafc.6b01707","volume":"64","author":"B Guo","year":"2016","unstructured":"Guo B, Zheng C, Cai W, Cheng J, Wang H, Li H, Sun Y, Cui W et al (2016) Multifunction of chrysin in Parkinson\u2019s model: anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B. J Agric Food Chem 64(26):5324\u20135333. https:\/\/doi.org\/10.1021\/acs.jafc.6b01707","journal-title":"J Agric Food Chem"},{"issue":"4","key":"2203_CR75","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12017-016-8399-5","volume":"18","author":"S Hu","year":"2016","unstructured":"Hu S, Wang L, Mak S, Zhang Z, Xu D, Li H, Li Y, Hu Y et al (2016) Potent protection against MPP. NeuroMolecular Med 18(4):561\u2013572. https:\/\/doi.org\/10.1007\/s12017-016-8399-5","journal-title":"NeuroMolecular Med"},{"issue":"4","key":"2203_CR76","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12031-015-0638-y","volume":"57","author":"S Hu","year":"2015","unstructured":"Hu S, Cui W, Zhang Z, Mak S, Xu D, Li G, Hu Y, Wang Y et al (2015) Indirubin-3-oxime effectively prevents 6OHDA-induced neurotoxicity in PC12 cells via activating MEF2D through the inhibition of GSK3\u03b2. J Mol Neurosci 57(4):561\u2013570. https:\/\/doi.org\/10.1007\/s12031-015-0638-y","journal-title":"J Mol Neurosci"},{"issue":"18","key":"2203_CR77","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1089\/ars.2013.5399","volume":"20","author":"L Gao","year":"2014","unstructured":"Gao L, She H, Li W, Zeng J, Zhu J, Jones DP, Mao Z, Gao G et al (2014) Oxidation of survival factor MEF2D in neuronal death and Parkinson\u2019s disease. Antioxid Redox Signal 20(18):2936\u20132948. https:\/\/doi.org\/10.1089\/ars.2013.5399","journal-title":"Antioxid Redox Signal"},{"key":"2203_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-015-0258-z","volume":"12","author":"S Yang","year":"2015","unstructured":"Yang S, Gao L, Lu F, Wang B, Gao F, Zhu G, Cai Z, Lai J et al (2015) Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death. J Neuroinflammation 12:33. https:\/\/doi.org\/10.1186\/s12974-015-0258-z","journal-title":"J Neuroinflammation"},{"issue":"5910","key":"2203_CR79","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.1166088","volume":"323","author":"Q Yang","year":"2009","unstructured":"Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, Mao Z (2009) Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 323(5910):124\u2013127. https:\/\/doi.org\/10.1126\/science.1166088","journal-title":"Science"},{"key":"2203_CR80","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.phrs.2017.02.004","volume":"119","author":"G Watson","year":"2017","unstructured":"Watson G, Ronai ZA, Lau E (2017) ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. Pharmacol Res 119:347\u2013357. https:\/\/doi.org\/10.1016\/j.phrs.2017.02.004","journal-title":"Pharmacol Res"},{"key":"2203_CR81","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2015.10.010","volume":"277","author":"Q Huang","year":"2016","unstructured":"Huang Q, Du X, He X, Yu Q, Hu K, Breitwieser W, Shen Q, Ma S et al (2016) JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 277:296\u2013304. https:\/\/doi.org\/10.1016\/j.expneurol.2015.10.010","journal-title":"Exp Neurol"},{"issue":"3","key":"2203_CR82","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jnr.21510","volume":"86","author":"M Kojima","year":"2008","unstructured":"Kojima M, Suzuki T, Maekawa T, Ishii S, Sumi-Ichinose C, Nomura T, Ichinose H (2008) Increased expression of tyrosine hydroxylase and anomalous neurites in catecholaminergic neurons of ATF-2 null mice. J Neurosci Res 86(3):544\u2013552. https:\/\/doi.org\/10.1002\/jnr.21510","journal-title":"J Neurosci Res"},{"issue":"2","key":"2203_CR83","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neuroscience.2005.02.029","volume":"133","author":"AG Pearson","year":"2005","unstructured":"Pearson AG, Curtis MA, Waldvogel HJ, Faull RL, Dragunow M (2005) Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience 133(2):437\u2013451. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.02.029","journal-title":"Neuroscience"},{"issue":"2","key":"2203_CR84","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/s0006-8993(96)01356-x","volume":"749","author":"T Yamada","year":"1997","unstructured":"Yamada T, Yoshiyama Y, Kawaguchi N (1997) Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues. Brain Res 749(2):329\u2013334. https:\/\/doi.org\/10.1016\/s0006-8993(96)01356-x","journal-title":"Brain Res"},{"issue":"7","key":"2203_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011464","volume":"5","author":"A Kurz","year":"2010","unstructured":"Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, Bockhart V, Bonin M, Garc\u00eda-Arencibia M et al (2010) A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS One 5(7):e11464. https:\/\/doi.org\/10.1371\/journal.pone.0011464","journal-title":"PLoS One"},{"issue":"42","key":"2203_CR86","doi-asserted-by":"publisher","first-page":"30901","DOI":"10.1074\/jbc.M608694200","volume":"282","author":"C Ma","year":"2007","unstructured":"Ma C, Ying C, Yuan Z, Song B, Li D, Liu Y, Lai B, Li W et al (2007) dp5\/HRK is a c-Jun target gene and required for apoptosis induced by potassium deprivation in cerebellar granule neurons. J Biol Chem 282(42):30901\u201330909. https:\/\/doi.org\/10.1074\/jbc.M608694200","journal-title":"J Biol Chem"},{"issue":"9","key":"2203_CR87","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1128\/mcb.01344-08","volume":"29","author":"Z Yuan","year":"2009","unstructured":"Yuan Z, Gong S, Luo J, Zheng Z, Song B, Ma S, Guo J, Hu C et al (2009) Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol 29(9):2431\u20132442. https:\/\/doi.org\/10.1128\/mcb.01344-08","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2203_CR88","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1128\/MCB.19.5.3289","volume":"19","author":"SY Fuchs","year":"1999","unstructured":"Fuchs SY, Ronai Z (1999) Ubiquitination and degradation of ATF2 are dimerization dependent. Mol Cell Biol 19(5):3289\u20133298","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2203_CR89","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0169-328X(98)00239-3","volume":"62","author":"A Martin-Villalba","year":"1998","unstructured":"Martin-Villalba A, Winter C, Brecht S, Buschmann T, Zimmermann M, Herdegen T (1998) Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury. Brain Res Mol Brain Res 62(2):158\u2013166","journal-title":"Brain Res Mol Brain Res"},{"key":"2203_CR90","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-014-0093-y","volume":"2","author":"MD Li","year":"2014","unstructured":"Li MD, Burns TC, Morgan AA, Khatri P (2014) Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun 2:93. https:\/\/doi.org\/10.1186\/s40478-014-0093-y","journal-title":"Acta Neuropathol Commun"},{"issue":"2\u20133","key":"2203_CR91","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.mam.2012.05.008","volume":"34","author":"L Huang","year":"2013","unstructured":"Huang L, Tepaamorndech S (2013) The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol Asp Med 34(2\u20133):548\u2013560. https:\/\/doi.org\/10.1016\/j.mam.2012.05.008","journal-title":"Mol Asp Med"},{"issue":"5","key":"2203_CR92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1357-2725(01)00156-X","volume":"34","author":"DL Sim","year":"2002","unstructured":"Sim DL, Yeo WM, Chow VT (2002) The novel human HUEL (C4orf1) protein shares homology with the DNA-binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner. Int J Biochem Cell Biol 34(5):487\u2013504","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2203_CR93","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/nar\/gkm095","volume":"35","author":"YH Chen","year":"2007","unstructured":"Chen YH, Yang CK, Xia M, Ou CY, Stallcup MR (2007) Role of GAC63 in transcriptional activation mediated by beta-catenin. Nucleic Acids Res 35(6):2084\u20132092. https:\/\/doi.org\/10.1093\/nar\/gkm095","journal-title":"Nucleic Acids Res"},{"key":"2203_CR94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2016.06.024","volume":"158","author":"R Libro","year":"2016","unstructured":"Libro R, Bramanti P, Mazzon E (2016) The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci 158:78\u201388. https:\/\/doi.org\/10.1016\/j.lfs.2016.06.024","journal-title":"Life Sci"},{"issue":"2","key":"2203_CR95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn2755","volume":"11","author":"NC Inestrosa","year":"2010","unstructured":"Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11(2):77\u201386. https:\/\/doi.org\/10.1038\/nrn2755","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2203_CR96","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2012.07.030","volume":"525","author":"Y Dun","year":"2012","unstructured":"Dun Y, Li G, Yang Y, Xiong Z, Feng M, Wang M, Zhang Y, Xiang J et al (2012) Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats. Neurosci Lett 525(2):83\u201388. https:\/\/doi.org\/10.1016\/j.neulet.2012.07.030","journal-title":"Neurosci Lett"},{"issue":"9","key":"2203_CR97","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models. FASEB J 23(9):2820\u20132830. https:\/\/doi.org\/10.1096\/fj.08-120410","journal-title":"FASEB J"},{"issue":"10","key":"2203_CR98","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1096\/fj.04-1551fje","volume":"18","author":"G Chen","year":"2004","unstructured":"Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 18(10):1162\u20131164. https:\/\/doi.org\/10.1096\/fj.04-1551fje","journal-title":"FASEB J"},{"issue":"2","key":"2203_CR99","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.nbd.2010.10.023","volume":"41","author":"F L\u2019Episcopo","year":"2011","unstructured":"L\u2019Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Cossetti C, D\u2019Adamo P, Zardini E et al (2011) Reactive astrocytes and Wnt\/\u03b2-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Neurobiol Dis 41(2):508\u2013527. https:\/\/doi.org\/10.1016\/j.nbd.2010.10.023","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2203_CR100","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","volume":"26","author":"I Cantuti-Castelvetri","year":"2007","unstructured":"Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG (2007) Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis 26(3):606\u2013614. https:\/\/doi.org\/10.1016\/j.nbd.2007.02.009","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2203_CR101","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1042\/bst20120122","volume":"40","author":"DC Berwick","year":"2012","unstructured":"Berwick DC, Harvey K (2012) The importance of Wnt signalling for neurodegeneration in Parkinson\u2019s disease. Biochem Soc Trans 40(5):1123\u20131128. https:\/\/doi.org\/10.1042\/bst20120122","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"2203_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000869","volume":"6","author":"AC Groner","year":"2010","unstructured":"Groner AC, Meylan S, Ciuffi A, Zangger N, Ambrosini G, D\u00e9nervaud N, Bucher P, Trono D (2010) KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 6(3):e1000869. https:\/\/doi.org\/10.1371\/journal.pgen.1000869","journal-title":"PLoS Genet"},{"issue":"15","key":"2203_CR103","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1242\/dev.132605","volume":"144","author":"G Ecco","year":"2017","unstructured":"Ecco G, Imbeault M, Trono D (2017) KRAB zinc finger proteins. Development 144(15):2719\u20132729. https:\/\/doi.org\/10.1242\/dev.132605","journal-title":"Development"},{"issue":"2","key":"2203_CR104","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/hmg\/ddw427","volume":"26","author":"T Busiello","year":"2017","unstructured":"Busiello T, Ciano M, Romano S, Sodaro G, Garofalo O, Bruzzese D, Simeone L, Chiurazzi F et al (2017) Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia. Hum Mol Genet 26(2):344\u2013353. https:\/\/doi.org\/10.1093\/hmg\/ddw427","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2203_CR105","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1074\/jbc.M109.063032","volume":"285","author":"S Frietze","year":"2010","unstructured":"Frietze S, Lan X, Jin VX, Farnham PJ (2010) Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 285(2):1393\u20131403. https:\/\/doi.org\/10.1074\/jbc.M109.063032","journal-title":"J Biol Chem"},{"issue":"11","key":"2203_CR106","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1091\/mbc.E17-11-0693","volume":"29","author":"YV Serebrenik","year":"2018","unstructured":"Serebrenik YV, Hellerschmied D, Toure M, L\u00f3pez-Gir\u00e1ldez F, Brookner D, Crews CM (2018) Targeted protein unfolding uncovers a Golgi-specific transcriptional stress response. Mol Biol Cell 29(11):1284\u20131298. https:\/\/doi.org\/10.1091\/mbc.E17-11-0693","journal-title":"Mol Biol Cell"},{"issue":"50","key":"2203_CR107","doi-asserted-by":"publisher","first-page":"48984","DOI":"10.1074\/jbc.M208194200","volume":"277","author":"N Gosavi","year":"2002","unstructured":"Gosavi N, Lee HJ, Lee JS, Patel S, Lee SJ (2002) Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J Biol Chem 277(50):48984\u201348992. https:\/\/doi.org\/10.1074\/jbc.M208194200","journal-title":"J Biol Chem"},{"key":"2203_CR108","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fnins.2015.00340","volume":"9","author":"G Joshi","year":"2015","unstructured":"Joshi G, Bekier ME, Wang Y (2015) Golgi fragmentation in Alzheimer\u2019s disease. Front Neurosci 9:340. https:\/\/doi.org\/10.3389\/fnins.2015.00340","journal-title":"Front Neurosci"},{"issue":"5785","key":"2203_CR109","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1126\/science.1129462","volume":"313","author":"AA Cooper","year":"2006","unstructured":"Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K et al (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models. Science 313(5785):324\u2013328. https:\/\/doi.org\/10.1126\/science.1129462","journal-title":"Science"},{"issue":"11","key":"2203_CR110","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1091\/mbc.e09-09-0801","volume":"21","author":"N Thayanidhi","year":"2010","unstructured":"Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, Hay JC (2010) Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs. Mol Biol Cell 21(11):1850\u20131863. https:\/\/doi.org\/10.1091\/mbc.e09-09-0801","journal-title":"Mol Biol Cell"},{"key":"2203_CR111","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng BY, Rose S, Jenner P (2010) A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Brain Res 1326:174\u2013183. https:\/\/doi.org\/10.1016\/j.brainres.2010.02.045","journal-title":"Brain Res"},{"issue":"3","key":"2203_CR112","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0304-3940(02)00296-3","volume":"326","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson\u2019s disease. Neurosci Lett 326(3):155\u2013158. https:\/\/doi.org\/10.1016\/s0304-3940(02)00296-3","journal-title":"Neurosci Lett"},{"key":"2203_CR113","doi-asserted-by":"publisher","unstructured":"Pe\u00f1alver-Gonz\u00e1lez B, Vallejo-Rodr\u00edguez J, Mentxaka G, Fullaondo A, Iglesias-Ara A, Field SJ, Zubiaga AM (2019) Golgi oncoprotein. Genes (Basel) 10(3). https:\/\/doi.org\/10.3390\/genes10030247","DOI":"10.3390\/genes10030247"},{"key":"2203_CR114","doi-asserted-by":"publisher","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, Ma\u2019ayan A (2016) The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) 2016.\u00a0https:\/\/doi.org\/10.1093\/database\/baw100","DOI":"10.1093\/database\/baw100"},{"key":"2203_CR115","doi-asserted-by":"publisher","unstructured":"Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, Rosen N, Kohn A, Twik M, Safran M, Lancet D, Cohen D (2017) GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford) 2017.\u00a0https:\/\/doi.org\/10.1093\/database\/bax028","DOI":"10.1093\/database\/bax028"},{"key":"2203_CR116","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-981-15-1025-0_13","volume":"1217","author":"P Wang","year":"2020","unstructured":"Wang P, Song J, Ye D (2020) CRL3s: The BTB-CUL3-RING E3 ubiquitin ligases. Adv Exp Med Biol 1217:211\u2013223. https:\/\/doi.org\/10.1007\/978-981-15-1025-0_13","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"2203_CR117","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tcb.2014.02.004","volume":"24","author":"T Welz","year":"2014","unstructured":"Welz T, Wellbourne-Wood J, Kerkhoff E (2014) Orchestration of cell surface proteins by Rab11. Trends Cell Biol 24(7):407\u2013415. https:\/\/doi.org\/10.1016\/j.tcb.2014.02.004","journal-title":"Trends Cell Biol"},{"issue":"9","key":"2203_CR118","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1073\/pnas.1000738107","volume":"107","author":"YI Yim","year":"2010","unstructured":"Yim YI, Sun T, Wu LG, Raimondi A, De Camilli P, Eisenberg E, Greene LE (2010) Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice. Proc Natl Acad Sci U S A 107(9):4412\u20134417. https:\/\/doi.org\/10.1073\/pnas.1000738107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2203_CR119","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","volume":"42","author":"M Nguyen","year":"2019","unstructured":"Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s disease. Trends Neurosci 42(2):140\u2013149. https:\/\/doi.org\/10.1016\/j.tins.2018.11.001","journal-title":"Trends Neurosci"},{"issue":"5","key":"2203_CR120","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.devcel.2012.01.018","volume":"22","author":"HM Kent","year":"2012","unstructured":"Kent HM, Evans PR, Sch\u00e4fer IB, Gray SR, Sanderson CM, Luzio JP, Peden AA, Owen DJ (2012) Structural basis of the intracellular sorting of the SNARE VAMP7 by the AP3 adaptor complex. Dev Cell 22(5):979\u2013988. https:\/\/doi.org\/10.1016\/j.devcel.2012.01.018","journal-title":"Dev Cell"},{"issue":"7","key":"2203_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000616","volume":"2","author":"JR van Weering","year":"2007","unstructured":"van Weering JR, Toonen RF, Verhage M (2007) The role of Rab3a in secretory vesicle docking requires association\/dissociation of guanidine phosphates and Munc18-1. PLoS One 2(7):e616. https:\/\/doi.org\/10.1371\/journal.pone.0000616","journal-title":"PLoS One"},{"issue":"5","key":"2203_CR122","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1091\/mbc.e08-05-0456","volume":"20","author":"K Newell-Litwa","year":"2009","unstructured":"Newell-Litwa K, Salazar G, Smith Y, Faundez V (2009) Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles. Mol Biol Cell 20(5):1441\u20131453. https:\/\/doi.org\/10.1091\/mbc.e08-05-0456","journal-title":"Mol Biol Cell"},{"issue":"6","key":"2203_CR123","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/jnc.13070","volume":"133","author":"C Alqu\u00e9zar","year":"2015","unstructured":"Alqu\u00e9zar C, Barrio E, Esteras N, de la Encarnaci\u00f3n A, Bartolom\u00e9 F, Molina JA, Mart\u00edn-Requero \u00c1 (2015) Targeting cyclin D3\/CDK6 activity for treatment of Parkinson\u2019s disease. J Neurochem 133(6):886\u2013897. https:\/\/doi.org\/10.1111\/jnc.13070","journal-title":"J Neurochem"},{"key":"2203_CR124","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2010.07.041","volume":"1354","author":"SK Kidd","year":"2010","unstructured":"Kidd SK, Schneider JS (2010) Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Brain Res 1354:172\u2013178. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.041","journal-title":"Brain Res"},{"issue":"20","key":"2203_CR125","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","volume":"15","author":"E Kontopoulos","year":"2006","unstructured":"Kontopoulos E, Parvin JD, Feany MB (2006) Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15(20):3012\u20133023. https:\/\/doi.org\/10.1093\/hmg\/ddl243","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2203_CR126","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","volume":"165","author":"SH Chen","year":"2012","unstructured":"Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q et al (2012) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol 165(2):494\u2013505. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01575.x","journal-title":"Br J Pharmacol"},{"key":"2203_CR127","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuropharm.2016.01.025","volume":"105","author":"S Sharma","year":"2016","unstructured":"Sharma S, Taliyan R (2016) Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice. Neuropharmacology 105:285\u2013297. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.025","journal-title":"Neuropharmacology"},{"issue":"4","key":"2203_CR128","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 35(4):870\u2013880. https:\/\/doi.org\/10.1038\/npp.2009.197","journal-title":"Neuropsychopharmacology"},{"key":"2203_CR129","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fgene.2014.00220","volume":"5","author":"F Copped\u00e8","year":"2014","unstructured":"Copped\u00e8 F (2014) The potential of epigenetic therapies in neurodegenerative diseases. Front Genet 5:220. https:\/\/doi.org\/10.3389\/fgene.2014.00220","journal-title":"Front Genet"},{"issue":"1","key":"2203_CR130","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","volume":"140","author":"IF Harrison","year":"2013","unstructured":"Harrison IF, Dexter DT (2013) Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u2019s disease? Pharmacol Ther 140(1):34\u201352. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.05.010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2203_CR131","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","volume":"62","author":"KC Dietz","year":"2010","unstructured":"Dietz KC, Casaccia P (2010) HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol Res 62(1):11\u201317. https:\/\/doi.org\/10.1016\/j.phrs.2010.01.011","journal-title":"Pharmacol Res"},{"issue":"24","key":"2203_CR132","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","volume":"22","author":"C Rouaux","year":"2003","unstructured":"Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL (2003) Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22(24):6537\u20136549. https:\/\/doi.org\/10.1093\/emboj\/cdg615","journal-title":"EMBO J"},{"issue":"4","key":"2203_CR133","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","volume":"13","author":"RN Saha","year":"2006","unstructured":"Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13(4):539\u2013550. https:\/\/doi.org\/10.1038\/sj.cdd.4401769","journal-title":"Cell Death Differ"},{"key":"2203_CR134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT (2018) Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett 666:48\u201357. https:\/\/doi.org\/10.1016\/j.neulet.2017.12.037","journal-title":"Neurosci Lett"},{"issue":"1","key":"2203_CR135","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","volume":"149","author":"PS Chen","year":"2007","unstructured":"Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, Lu RB, Gean PW et al (2007) Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149(1):203\u2013212. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.06.053","journal-title":"Neuroscience"},{"issue":"1","key":"2203_CR136","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","volume":"134","author":"GS Peng","year":"2005","unstructured":"Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, Yang S, Hong JS (2005) Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res Mol Brain Res 134(1):162\u2013169. https:\/\/doi.org\/10.1016\/j.molbrainres.2004.10.021","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"2203_CR137","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mdc3.12242","volume":"3","author":"A Djamshidian","year":"2016","unstructured":"Djamshidian A, Bernschneider-Reif S, Poewe W, Lees AJ (2016) Banisteriopsis caapi, a forgotten potential therapy for Parkinson\u2019s disease? Movement Disorders Clinical Practice 3(1):19\u201326. https:\/\/doi.org\/10.1002\/mdc3.12242","journal-title":"Movement Disorders Clinical Practice"},{"issue":"1","key":"2203_CR138","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/14734220601016080","volume":"6","author":"H Miwa","year":"2007","unstructured":"Miwa H (2007) Rodent models of tremor. Cerebellum 6(1):66\u201372. https:\/\/doi.org\/10.1080\/14734220601016080","journal-title":"Cerebellum"},{"issue":"2","key":"2203_CR139","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GH, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 10(2):195\u2013223","journal-title":"J Ethnopharmacol"},{"issue":"8\u20139","key":"2203_CR140","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/bf01291787","volume":"103","author":"MS Reid","year":"1996","unstructured":"Reid MS, Hsu K, Souza KH, Broderick PA, Berger SP (1996) Neuropharmacological characterization of local ibogaine effects on dopamine release. J Neural Transm (Vienna) 103(8\u20139):967\u2013985. https:\/\/doi.org\/10.1007\/bf01291787","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"2203_CR141","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0091-3057(03)00129-1","volume":"75","author":"MJ Schwarz","year":"2003","unstructured":"Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD (2003) Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacol Biochem Behav 75(3):627\u2013633","journal-title":"Pharmacol Biochem Behav"},{"key":"2203_CR142","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fphar.2018.00346","volume":"9","author":"SP Li","year":"2018","unstructured":"Li SP, Wang YW, Qi SL, Zhang YP, Deng G, Ding WZ, Ma C, Lin QY et al (2018) Analogous \u03b2-carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol 9:346. https:\/\/doi.org\/10.3389\/fphar.2018.00346","journal-title":"Front Pharmacol"},{"issue":"2","key":"2203_CR143","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","volume":"221","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) The cholinergic system and Parkinson disease. Behav Brain Res 221(2):564\u2013573. https:\/\/doi.org\/10.1016\/j.bbr.2009.12.048","journal-title":"Behav Brain Res"},{"issue":"9","key":"2203_CR144","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","volume":"13","author":"ML M\u00fcller","year":"2013","unstructured":"M\u00fcller ML, Bohnen NI (2013) Cholinergic dysfunction in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 13(9):377. https:\/\/doi.org\/10.1007\/s11910-013-0377-9","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2203_CR145","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","volume":"7","author":"JA Morales-Garc\u00eda","year":"2017","unstructured":"Morales-Garc\u00eda JA, de la Fuente Revenga M, Alonso-Gil S, Rodr\u00edguez-Franco MI, Feilding A, Perez-Castillo A, Riba J (2017) The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro. Sci Rep 7(1):5309. https:\/\/doi.org\/10.1038\/s41598-017-05407-9","journal-title":"Sci Rep"},{"issue":"2","key":"2203_CR146","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1471-4159.2000.0750521.x","volume":"75","author":"CS Lee","year":"2000","unstructured":"Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE (2000) Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. J Neurochem 75(2):521\u2013531","journal-title":"J Neurochem"},{"issue":"10","key":"2203_CR147","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1046\/j.0953-816x.2001.01563.x","volume":"13","author":"DH Kim","year":"2001","unstructured":"Kim DH, Jang YY, Han ES, Lee CS (2001) Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. Eur J Neurosci 13(10):1861\u20131872","journal-title":"Eur J Neurosci"},{"issue":"9","key":"2203_CR148","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2174\/092986711795029546","volume":"18","author":"JK Shin","year":"2011","unstructured":"Shin JK, Malone DT, Crosby IT, Capuano B (2011) Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action. Curr Med Chem 18(9):1380\u20131404","journal-title":"Curr Med Chem"},{"issue":"1","key":"2203_CR149","first-page":"238","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251(1):238\u2013246","journal-title":"J Pharmacol Exp Ther"},{"key":"2203_CR150","doi-asserted-by":"crossref","unstructured":"Stancer HC, Garfinkel PE, Rakoff VM (eds) (1985) Guidelines for the use of psychotropic drugs: a clinical handbook. Springer Science & Business Media, Berlin","DOI":"10.1007\/978-94-011-7618-7"},{"key":"2203_CR151","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnmol.2011.00038","volume":"4","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Del\u2019guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 4:38. https:\/\/doi.org\/10.3389\/fnmol.2011.00038","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2203_CR152","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63(1):182\u2013217. https:\/\/doi.org\/10.1124\/pr.110.002642","journal-title":"Pharmacol Rev"},{"key":"2203_CR153","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","volume":"97","author":"M Golpich","year":"2015","unstructured":"Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L et al (2015) Glycogen synthase kinase-3 beta (GSK-3beta) signaling: Implications for Parkinson\u2019s disease. Pharmacol Res 97:16\u201326. https:\/\/doi.org\/10.1016\/j.phrs.2015.03.010","journal-title":"Pharmacol Res"},{"issue":"4","key":"2203_CR154","first-page":"790","volume":"60","author":"I Wenningmann","year":"2001","unstructured":"Wenningmann I, Dilger JP (2001) The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium. Mol Pharmacol 60(4):790\u2013796","journal-title":"Mol Pharmacol"},{"issue":"6","key":"2203_CR155","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/ALN.0b013e31819fade3","volume":"110","author":"M Jonsson Fagerlund","year":"2009","unstructured":"Jonsson Fagerlund M, Dabrowski M, Eriksson LI (2009) Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology 110(6):1244\u20131252. https:\/\/doi.org\/10.1097\/ALN.0b013e31819fade3","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"2203_CR156","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3940(90)90796-C","volume":"110","author":"JA Peters","year":"1990","unstructured":"Peters JA, Malone HM, Lambert JJ (1990) Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine. Neurosci Lett 110(1\u20132):107\u2013112","journal-title":"Neurosci Lett"},{"issue":"2","key":"2203_CR157","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0009-2797(01)00294-0","volume":"139","author":"M Golicnik","year":"2002","unstructured":"Golicnik M, Fournier D, Stojan J (2002) Acceleration of Drosophila melanogaster acetylcholinesterase methanesulfonylation: peripheral ligand D-tubocurarine enhances the affinity for small methanesulfonylfluoride. Chem Biol Interact 139(2):145\u2013157","journal-title":"Chem Biol Interact"},{"issue":"1","key":"2203_CR158","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1476-5381.1950.tb00576.x","volume":"5","author":"S Salama","year":"1950","unstructured":"Salama S, Wright S (1950) Action of d-tubocurarine chloride on the central nervous system of the cat. Br J Pharmacol Chemother 5(1):49\u201361","journal-title":"Br J Pharmacol Chemother"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-020-02203-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:10:13Z","timestamp":1614849013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-020-02203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":158,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02203-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}